EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Macrophage ATG16L1 expression suppresses metabolic dysfunction-associated steatohepatitis progression by promoting lipophagy

Qi Wang, Qingfa Bu, Zibo Xu, Yuan Liang, Jinren Zhou, Yufeng Pan, Haoming Zhou, Ling Lu

Clinical and Molecular Hepatology · 01.07.2024 · 30 (3) · 515-538

DOI: 10.3350/cmh.2024.0107 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical and Molecular Hepatology, erschienen am 01.07.2024. Verfasst von Qi Wang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, First Affiliated Hospital of Anhui Medical University, Hefei, China. Hauptthemen laut MEDLINE: Autophagy-Related Proteins, Macrophages, Autophagy, Membrane Proteins. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0). Gefördert von: National Natural Science Foundation of China, CAMS Innovation Fund for Medical Sciences, Postgraduate Research & Practice Innovation Program of Jiangsu Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Aims: Metabolic dysfunction-associated steatohepatitis (MASH) is an unmet clinical challenge due to the rapid increased occurrence but lacking approved drugs. Autophagy-related protein 16-like 1 (ATG16L1) plays an important role in the process of autophagy, which is indispensable for proper biogenesis of the autophagosome, but its role in modulating macrophage-related inflammation and metabolism during MASH has not been documented. Here, we aimed to elucidate the role of ATG16L1 in the progression of MASH.

Methods

Expression analysis was performed with liver samples from human and mice. MASH models were induced in myeloid-specific Atg16l1-deficient and myeloid-specific Atg16l1-overexpressed mice by high-fat and high-cholesterol diet or methionine- and choline-deficient diet to explore the function and mechanism of macrophage ATG16L1 in MASH.

Results

Macrophage-specific Atg16l1 knockout exacerbated MASH and inhibited energy expenditure, whereas macrophage-specific Atg16l1 transgenic overexpression attenuated MASH and promotes energy expenditure. Mechanistically, Atg16l1 knockout inhibited macrophage lipophagy, thereby suppressing macrophage β-oxidation and decreasing the production of 4-hydroxynonenal, which further inhibited stimulator of interferon genes(STING) carbonylation. STING palmitoylation was enhanced, STING trafficking from the endoplasmic reticulum to the Golgi was promoted, and downstream STING signaling was activated, promoting proinflammatory and profibrotic cytokines secretion, resulting in hepatic steatosis and hepatic stellate cells activation. Moreover, Atg16l1-deficiency enhanced macrophage phagosome ability but inhibited lysosome formation, engulfing mtDNA released by pyroptotic hepatocytes. Increased mtDNA promoted cGAS/STING signaling activation. Moreover, pharmacological promotion of ATG16L1 substantially blocked MASH progression.

Conclusions

ATG16L1 suppresses MASH progression by maintaining macrophage lipophagy, restraining liver inflammation, and may be a promising therapeutic target for MASH management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Autophagy-Related ProteinsMacrophagesAutophagyMembrane ProteinsAnimalsMiceHumansMaleDisease ProgressionMice, KnockoutDisease Models, AnimalFatty LiverDiet, High-FatEnergy MetabolismLiverSignal TransductionMice, Inbred C57BLSTING Protein

Stichwörter der Autor:innen

ATG16L1LipophagyMacrophagesMetabolic dysfunction-associated steatohepatitis

Substanzen

Autophagy-Related ProteinsMembrane ProteinsAtg16l1 protein, mouseSting1 protein, mouseSTING ProteinATG16L1 protein, human

Autor:innen und Institutionen

  • Department of General Surgery, First Affiliated Hospital of Anhui Medical University, Hefei, China.
  • Hepatobiliary Center, The First Affiliated Hospital of Nanjing Medical University, Research Unit of Liver Transplantation and Transplant Immunology, Chinese Academy of Medical Sciences, Nanjing, China.
  • Department of General Surgery, Nanjing BenQ Medical Center, The Affiliated BenQ Hospital of Nanjing Medical University, Nanjing, China.
  • Affiliated Hospital of Xuzhou Medical University, Xuzhou, China.

Förderung

  • National Natural Science Foundation of China
  • CAMS Innovation Fund for Medical Sciences
  • Postgraduate Research & Practice Innovation Program of Jiangsu Province

Zitieren

APA

Wang, Q., Bu, Q., Xu, Z., Liang, Y., Zhou, J., Pan, Y., Zhou, H., & Lu, L. (2024). Macrophage ATG16L1 expression suppresses metabolic dysfunction-associated steatohepatitis progression by promoting lipophagy. Clinical and Molecular Hepatology, 30(3), 515-538. https://doi.org/10.3350/cmh.2024.0107

Vancouver

Wang Q, Bu Q, Xu Z, Liang Y, Zhou J, Pan Y, et al. Macrophage ATG16L1 expression suppresses metabolic dysfunction-associated steatohepatitis progression by promoting lipophagy. Clinical and Molecular Hepatology. 2024;30(3):515-538. doi:10.3350/cmh.2024.0107

BibTeX
@article{Wang2024,
  author = {Wang, Qi and Bu, Qingfa and Xu, Zibo and Liang, Yuan and Zhou, Jinren and Pan, Yufeng and Zhou, Haoming and Lu, Ling},
  title = {Macrophage ATG16L1 expression suppresses metabolic dysfunction-associated steatohepatitis progression by promoting lipophagy},
  journal = {Clinical and Molecular Hepatology},
  year = {2024},
  volume = {30},
  number = {3},
  pages = {515--538},
  doi = {10.3350/cmh.2024.0107}
}
Kostenlos starten →